William D Haire

Summary

Affiliation: University of Nebraska Medical Center
Country: USA

Publications

  1. ncbi Pancytopenia due to iron deficiency worsened by iron infusion: a case report
    Apar Kishor Ganti
    Department of Internal Medicine, Division of Oncology Hematology, University of Nebraska Medical Center, Omaha, NE, USA
    J Med Case Reports 1:175. 2007
  2. ncbi Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial
    William D Haire
    University of Nebraska Medical Center, Section of Oncology Hematology, 987680 Nebraka Medical Center, Omaha, Nebraska 68198 7680, USA
    Thromb Haemost 92:575-82. 2004
  3. ncbi Hematopoietic stem cell transplantation for Hodgkin's disease in a patient with dysfibrinogenemia and thrombosis
    Apar Kishor Ganti
    Department of Internal Medicine, Section of Oncology Hematology, University of Nebraska Medical Center, 987680 Nebraska Medical Center, Omaha, NE 68198 7680, USA
    J Thromb Thrombolysis 23:155-8. 2007
  4. ncbi Multiple organ dysfunction syndrome in hematopoietic stem cell transplantation
    William D Haire
    Department of Internal Medicine, Section of Oncology and Hematology, University of Nebraska Medical Center, Omaha, NE, USA
    Crit Care Med 30:S257-62. 2002
  5. ncbi Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial
    Petr Svoboda
    Intensive Care, Traumatological Hospital, Masaryk University of Brno, Czech Republic
    Crit Care Med 32:1990-6. 2004
  6. ncbi Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism
    William D Haire
    Curr Hematol Rep 2:405-6. 2003

Collaborators

  • Apar Kishor Ganti
  • Steven R Deitcher
  • J Vose
  • Petr Svoboda
  • Tamyra L Mouginis
  • Debra M Schuerr
  • Michael R Jaff
  • R Philip Barton
  • Gregory A Schulz
  • Carolyn M Firszt
  • Mohamed A El-Shahawy
  • Brian R Jacobs
  • Olga L Barbarash
  • Alexey A Butylin
  • Jan Lata
  • Lewis B Schwartz

Detail Information

Publications6

  1. ncbi Pancytopenia due to iron deficiency worsened by iron infusion: a case report
    Apar Kishor Ganti
    Department of Internal Medicine, Division of Oncology Hematology, University of Nebraska Medical Center, Omaha, NE, USA
    J Med Case Reports 1:175. 2007
    ..Much less common is the development of thrombocytopenia following replenishment of iron stores...
  2. ncbi Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial
    William D Haire
    University of Nebraska Medical Center, Section of Oncology Hematology, 987680 Nebraka Medical Center, Omaha, Nebraska 68198 7680, USA
    Thromb Haemost 92:575-82. 2004
    ..In conclusion, r-UK is superior to placebo in restoring total catheter patency to occluded CVADs. In patients with occluded CVADs, intra-catheter thrombolysis can restore patency and may obviate the need for catheter replacement...
  3. ncbi Hematopoietic stem cell transplantation for Hodgkin's disease in a patient with dysfibrinogenemia and thrombosis
    Apar Kishor Ganti
    Department of Internal Medicine, Section of Oncology Hematology, University of Nebraska Medical Center, 987680 Nebraska Medical Center, Omaha, NE 68198 7680, USA
    J Thromb Thrombolysis 23:155-8. 2007
    ..Management of patients with dysfibrinogenemia and a thrombotic tendency usually involves long-term anticoagulation...
  4. ncbi Multiple organ dysfunction syndrome in hematopoietic stem cell transplantation
    William D Haire
    Department of Internal Medicine, Section of Oncology and Hematology, University of Nebraska Medical Center, Omaha, NE, USA
    Crit Care Med 30:S257-62. 2002
    ....
  5. ncbi Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial
    Petr Svoboda
    Intensive Care, Traumatological Hospital, Masaryk University of Brno, Czech Republic
    Crit Care Med 32:1990-6. 2004
    ..The median +/- sd time to patency was 15 +/- 20.8 mins (range, 5-203 mins). CONCLUSION: The use of a new r-UK, 5000 IU/mL, is safe and effective for the restoration of patency to occluded CVADs...
  6. ncbi Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism
    William D Haire
    Curr Hematol Rep 2:405-6. 2003